NCT01736527

Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation

Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% at 6, 9, 12, and 24 Hours Following a Single Instillation in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Bausch & Lomb Incorporated · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To assess the levels of loteprednol etabonate (LE) in tear fluid following a single topical instillation of LE ophthalmic gel 0.5% formulation to healthy volunteers.

Conditions

• Pharmacokinetics

Interventions

Type	Name	Description
DRUG	LE Gel	Single drop of LE Gel 0.5% administered to the study eye on visit 2

Timeline

• Start date: 2013-01-01
• Primary completion: 2013-01-01
• Completion: 2013-04-01
• First posted: 2012-11-29
• Last updated: 2013-11-08
• Results posted: 2013-11-08

Locations

1 site across 1 country: United States